Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NUVL

Nuvalent (NUVL)

Nuvalent Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NUVL
DateTimeSourceHeadlineSymbolCompany
05/17/20243:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUVLNuvalent Inc
05/16/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUVLNuvalent Inc
05/16/20243:01PMPR Newswire (US)Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655NASDAQ:NUVLNuvalent Inc
05/15/20243:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUVLNuvalent Inc
05/09/20245:46AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NUVLNuvalent Inc
05/09/20245:37AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUVLNuvalent Inc
05/09/20245:30AMPR Newswire (US)Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial ResultsNASDAQ:NUVLNuvalent Inc
05/08/20243:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUVLNuvalent Inc
04/08/20243:30PMPR Newswire (US)Nuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2024NASDAQ:NUVLNuvalent Inc
03/05/20243:52PMPR Newswire (US)Nuvalent to Present New Preclinical Data on HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, zidesamtinib, at AACR Annual Meeting 2024NASDAQ:NUVLNuvalent Inc
02/27/20246:00AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NUVLNuvalent Inc
02/27/20245:42AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NUVLNuvalent Inc
02/27/20245:38AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUVLNuvalent Inc
02/27/20245:30AMPR Newswire (US)Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:NUVLNuvalent Inc
02/27/20245:15AMPR Newswire (US)Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-520NASDAQ:NUVLNuvalent Inc
02/12/20245:30AMPR Newswire (US)Nuvalent Initiates the Phase 2 Portion of ALKOVE-1 Clinical Trial for Patients with ALK-Positive NSCLC and other Solid TumorsNASDAQ:NUVLNuvalent Inc
02/01/20245:30AMPR Newswire (US)Nuvalent to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:NUVLNuvalent Inc
01/09/20243:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUVLNuvalent Inc
01/09/20243:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUVLNuvalent Inc
01/09/20243:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUVLNuvalent Inc
01/09/20243:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUVLNuvalent Inc
01/09/20243:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUVLNuvalent Inc
01/09/20243:40PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUVLNuvalent Inc
01/08/20245:30AMPR Newswire (US)Nuvalent Announces "OnTarget 2026" Operating Plan and Key Anticipated MilestonesNASDAQ:NUVLNuvalent Inc
12/28/20234:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUVLNuvalent Inc
12/26/20233:31PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NUVLNuvalent Inc
12/21/20235:30AMPR Newswire (US)Nuvalent to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:NUVLNuvalent Inc
12/20/20233:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUVLNuvalent Inc
12/20/20233:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUVLNuvalent Inc
12/20/20233:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUVLNuvalent Inc
 Showing the most relevant articles for your search:NASDAQ:NUVL